Prelude Capital Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,053
Closed -$397K 1445
2026
Q1
$397K Buy
+9,053
New +$413K 0.03% 606
2020
Q4
Sell
-3,558
Closed -$107K 1780
2020
Q3
$107K Buy
3,558
+1,747
+96% +$54.5K 0.01% 880
2020
Q2
$54K Buy
+1,811
New +$53.6K ﹤0.01% 1140
2020
Q1
Sell
-12,413
Closed -$526K 1862
2019
Q4
$526K Buy
+12,413
New +$525K 0.02% 551
2018
Q3
Sell
-862
Closed -$27.4K 1955
2018
Q2
$27K Buy
+862
New +$24.6K ﹤0.01% 1283
2018
Q1
Sell
-1,805
Closed -$50K 1660
2017
Q4
$50K Buy
+1,805
New +$52.1K ﹤0.01% 939
2016
Q4
Sell
-440
Closed -$16K 1718
2016
Q3
$16K Buy
+440
New +$15.6K ﹤0.01% 1369
2015
Q1
Sell
-1,000
Closed -$39K 2091
2014
Q4
$39K Buy
+1,000
New +$37.9K 0.01% 1401
2014
Q3
Sell
-1,000
Closed -$37K 2051
2014
Q2
$37K Sell
1,000
-100
-9% -$3.57K ﹤0.01% 1540
2014
Q1
$37K Buy
1,100
+100
+10% +$3.18K 0.01% 1424
2013
Q4
$30K Hold
1,000
0.01% 1276
2013
Q3
$30K Buy
+1,000
New +$30.4K ﹤0.01% 1133

Other funds holding OHI

Prelude Capital Management's OHI Position: Q2 2026 in Review

Prelude Capital Management sold out of Omega Healthcare (OHI) in Q2 2026, closing a stake of 9,053 shares — an estimated $397K sold.

Prelude Capital Management first reported a position in OHI in Q3 2013 and held it in 12 quarters. The position peaked at $526K in Q4 2019. 762 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Prelude Capital Management reported no remaining Omega Healthcare position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 9,053 Omega Healthcare shares in Q2 2026, an estimated $397K.
  • Prelude Capital Management first reported a position in Omega Healthcare in Q3 2013 and held it in 12 quarters.
  • Prelude Capital Management's Omega Healthcare position peaked at $526K in Q4 2019.
  • 762 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.